Editor's Note: TheStreet ratings do not represent the views of TheStreet's staff or its contributors. Ratings are established by computer based on metrics for performance (which includes growth, stock performance, efficiency and valuation) and risk (volatility and solvency). Companies with poor cash flow or high debt levels tend to earn lower ratings in our model

Edwards Life



) pushed the Health Services industry higher today making it today's featured health services winner. The industry as a whole closed the day down 0.4%. By the end of trading, Edwards Life rose $1.51 (2.3%) to $66.46 on average volume. Throughout the day, 2,026,122 shares of Edwards Life exchanged hands as compared to its average daily volume of 1,462,600 shares. The stock ranged in a price between $64.25-$67.29 after having opened the day at $64.65 as compared to the previous trading day's close of $64.95. Other companies within the Health Services industry that increased today were:




), up 18.8%,

MGC Diagnostics



), up 12.9%,

Kips Bay Medical



), up 8.6% and




), up 8.0%.

  • EXCLUSIVE OFFER: Jim Cramer's Protégé, Dave Peltier, only buys Stocks Under $10 that he thinks could potentially double. See what he's trading today with a 14-day FREE pass.

Edwards Lifesciences Corporation provides products and technologies to treat structural heart disease and critically ill patients worldwide. Edwards Life has a market cap of $7.3 billion and is part of the health care sector. The company has a P/E ratio of 20.3, above the S&P 500 P/E ratio of 17.7. Shares are down 28.0% year to date as of the close of trading on Thursday. Currently there are 8 analysts that rate Edwards Life a buy, 1 analyst rates it a sell, and 9 rate it a hold.

TheStreet Ratings rates

Edwards Life

as a


. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, notable return on equity, expanding profit margins and good cash flow from operations. We feel these strengths outweigh the fact that the company has had lackluster performance in the stock itself.

On the negative front,

Escalon Medical Corporation



), down 12.5%,

Bovie Medical Corporation



), down 11.7%,

SunLink Health Systems



), down 6.2% and

ImmunoCellular Therapeutics



), down 5.4% , were all laggards within the health services industry with

Express Scripts



) being today's health services industry laggard.

For investors not wanting singular stock exposure, ETFs may be of interest. Investors who are bullish on the health services industry could consider

Health Care Select Sector SPDR



) while those bearish on the health services industry could consider

ProShares Ultra Short Health Care




3x UPSIDE POTENTIAL: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.